Position in ALVO
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$4,792,077
-$2,565,127 QoQ
Shares Held
1,397,107
-2.6% QoQ
Ownership
0.413%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2025
5 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ALVO Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Mar 31, 2026PRICE T ROWE ASSOCIATES INC /MD/ holds $1,875,467,383 across 39 Drug Manufacturers - Specialty & Generic names. ALVO ranks #13 (0.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VTRS |
Viatris Inc
|
65,864,104 | $889,824,044 | |
| 2 | UTHR |
UNITED THERAPEUTICS Corp
|
405,447 | $240,421,961 | |
| 3 | ALKS |
Alkermes plc.
|
4,664,576 | $164,939,406 | |
| 4 | PRGO |
PERRIGO Co plc
|
13,376,776 | $143,666,573 | |
| 5 | ZTS |
Zoetis Inc.
|
1,018,088 | $120,348,181 | |
| 6 | ELAN |
Elanco Animal Health Inc
|
3,201,490 | $76,611,655 | |
| 7 | LNTH |
Lantheus Holdings, Inc.
|
919,732 | $69,761,671 | |
| 8 | LQDA |
Liquidia Corp
|
953,151 | $35,971,917 |
All Filings in ALVO
Export CSV
5 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $4,792,077 | 1,397,107 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $7,357,204 | 1,434,153 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $11,905,884 | 1,453,710 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $12,675,988 | 1,389,911 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $13,551,741 | 1,401,421 | Shares | Defined | 2025-05-14 | |
| No filing history on record for this holder in this stock. | ||||||